# Lucid Diagnostics Inc.: filings

LUCD · Nasdaq · CIK 1799011 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lucd.md) · [Financials](/companies/lucd/financials.md) · [Filings](/companies/lucd/filings.md) · [Insiders](/companies/lucd/insiders.md)

## Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 71, 4 59, 10-Q 15, 3 15, CORRESP 10, S-8 10, 424B5 9, UPLOAD 8, DEFA14A 7, EFFECT 7, DEF 14A 6, PRE 14A 6, 10-K 5, S-3 5, 424B3 4, D 4, S-1/A 4, SC 13D/A 4, 4/A 3, ARS 3, DRS/A 2, DRSLTR 2, S-1 2, S-3/A 2, SC 13G 2, SC 13G/A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 144 1, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, NT 10-K 1, SC 13D 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:34 ET | [8-K](/filings/0001493152-26-048114.md) | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-048114 |
| 2026-10-16 | 20:30 ET | [8-K](/filings/0001493152-26-047404.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-047404 |
| 2026-09-22 | 13:06 ET | [8-K](/filings/0001493152-26-043659.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043659 |
| 2026-08-13 | 12:23 ET | [8-K](/filings/0001493152-26-037596.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037596 |
| 2026-08-12 | 20:30 ET | [10-Q](/filings/0001437749-26-027335.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027335 |
| 2026-06-24 | 21:00 ET | [8-K](/filings/0001493152-26-029943.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029943 |
| 2026-05-14 | 12:05 ET | [8-K](/filings/0001493152-26-022877.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-022877 |
| 2026-05-13 | 20:31 ET | [10-Q](/filings/0001437749-26-016751.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016751 |
| 2026-04-30 | 21:00 ET | [DEF 14A](/filings/0001493152-26-020708.md) | Proxy statement, period 2026-04-30 | 0001493152-26-020708 |
| 2026-04-24 | 20:30 ET | [8-K](/filings/0001493152-26-018926.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018926 |
| 2026-04-23 | 20:30 ET | [8-K](/filings/0001493152-26-018725.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018725 |
| 2026-03-26 | 12:00 ET | [8-K](/filings/0001493152-26-012807.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012807 |
| 2026-03-25 | 20:56 ET | [10-K](/filings/0001437749-26-009805.md) | Annual report, period 2025-12-31 | 0001437749-26-009805 |
| 2026-02-09 | 23:41 ET | [SCHEDULE 13D/A](/filings/0001094891-26-000053.md) | Ownership report, active investor, amended | 0001094891-26-000053 |
| 2025-11-12 | 13:15 ET | [8-K](/filings/0001493152-25-021748.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021748 |
| 2025-11-12 | 13:01 ET | [10-Q](/filings/0001493152-25-021737.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021737 |
| 2025-10-10 | 01:45 ET | [SCHEDULE 13D/A](/filings/0001493152-25-017859.md) | Ownership report, active investor, amended | 0001493152-25-017859 |
| 2025-09-25 | 12:57 ET | [8-K](/filings/0001493152-25-014872.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-014872 |
| 2025-09-11 | 13:27 ET | [8-K](/filings/0001493152-25-013046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013046 |
| 2025-09-10 | 13:15 ET | [8-K](/filings/0001493152-25-012962.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012962 |
| 2025-08-13 | 12:00 ET | [8-K](/filings/0001493152-25-011882.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011882 |
| 2025-08-12 | 21:29 ET | [10-Q](/filings/0001493152-25-011862.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011862 |
| 2025-06-18 | 21:00 ET | [8-K](/filings/0001641172-25-015613.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015613 |
| 2025-05-30 | 20:35 ET | [8-K](/filings/0001641172-25-013059.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-013059 |
| 2025-05-14 | 12:20 ET | [8-K](/filings/0001641172-25-010101.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010101 |
| 2025-05-13 | 20:58 ET | [10-Q](/filings/0001641172-25-009986.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009986 |
| 2025-04-30 | 20:15 ET | [DEF 14A](/filings/0001641172-25-007766.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007766 |
| 2025-04-25 | 20:44 ET | [8-K](/filings/0001641172-25-006239.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-006239 |
| 2025-04-11 | 13:25 ET | [8-K](/filings/0001641172-25-003740.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003740 |
| 2025-04-10 | 12:30 ET | [8-K](/filings/0001641172-25-003526.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-003526 |
| 2025-03-25 | 12:00 ET | [8-K](/filings/0001641172-25-000514.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000514 |
| 2025-03-24 | 12:00 ET | [10-K](/filings/0001641172-25-000205.md) | Annual report, period 2024-12-31 | 0001641172-25-000205 |
| 2025-03-05 | 21:30 ET | [8-K](/filings/0001493152-25-009231.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-009231 |
| 2025-03-04 | 13:15 ET | [8-K](/filings/0001493152-25-008980.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008980 |
| 2025-03-04 | 12:56 ET | [8-K](/filings/0001493152-25-008974.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-008974 |
| 2025-02-25 | 23:38 ET | [8-K](/filings/0001493152-25-008100.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-008100 |
| 2024-12-20 | 21:15 ET | [8-K](/filings/0001493152-24-051061.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-051061 |
| 2024-12-12 | 21:30 ET | [SC 13D/A](/filings/0001493152-24-049793.md) | Ownership report, active investor, amended | 0001493152-24-049793 |
| 2024-11-29 | 21:15 ET | [8-K](/filings/0001493152-24-048170.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-048170 |
| 2024-11-18 | 22:27 ET | [8-K](/filings/0001493152-24-046587.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-046587 |
| 2024-11-13 | 13:15 ET | [8-K](/filings/0001493152-24-044974.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044974 |
| 2024-11-12 | 21:36 ET | [10-Q](/filings/0001493152-24-044799.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044799 |
| 2024-11-12 | 12:00 ET | [8-K](/filings/0001493152-24-044502.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-044502 |
| 2024-08-12 | 12:31 ET | [10-Q](/filings/0001493152-24-031168.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031168 |
| 2024-08-12 | 12:15 ET | [8-K](/filings/0001493152-24-031161.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-031161 |
| 2024-07-24 | 22:54 ET | [8-K](/filings/0001493152-24-028854.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-028854 |
| 2024-06-21 | 21:15 ET | [8-K](/filings/0001493152-24-024793.md) | 3.01 Delisting notice | 0001493152-24-024793 |
| 2024-06-06 | 13:48 ET | [DEF 14A](/filings/0001493152-24-022864.md) | Proxy statement, period 2024-06-06 | 0001493152-24-022864 |
| 2024-05-24 | 20:30 ET | [8-K](/filings/0001493152-24-021374.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021374 |
| 2024-05-14 | 10:05 ET | [8-K](/filings/0001493152-24-019020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-019020 |

Page 1 of 3. [Older](/companies/lucd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.